共 698 条
[1]
Mohyi M(2018)40 YEARS OF IGF1: IGF1 receptor and thyroid-associated ophthalmopathy J Mol Endocrinol 61 T29-T43
[2]
Smith TJ(2010)The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy Graves' Ophthalmopathy New Engl J Med 362 726-738
[3]
Bahn RS(2021)Risk factors in periodontology: a conceptual framework Eur J Endocrinol 185 G43-G67
[4]
Bartalena L(2017)Smoking and eye pathologies. A systemic review. Part II. Retina Diseases, Uveitis Optic Neuropathies, Thyroid-Associated Orbitopathy J Clin Periodontol 44 125-131
[5]
Kahaly GJ(2017)Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy Curr Pharm Design 23 639-654
[6]
Baldeschi L(2019)Cigarette Smoke Extract-Induced Oxidative Stress and Fibrosis-Related Genes Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy Eye 33 212-217
[7]
Dayan CM(2016)Differential involvement of orbital fat and extraocular muscles in graves' ophthalmopathy Oxid Med Cell Longev 2016 1-10
[8]
Eckstein A(2013)Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts-a possible explanation of the link between smoking and Graves' ophthalmopathy Eur Thyroid J 2 14-21
[9]
Marcocci C(2014)Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy—Implications for Smoking Int J Ophthalmol-Chi 7 403-407
[10]
Marino M(2016)Smoking Induces Overexpression of Immediate Early Genes in Active Graves' Ophthalmopathy J Clin Endocrinol Metab 101 4834-4842